Register Login

Coagulation Factors

Alternate Functions of AT, PC, PS, and TFPI

Go to your medical library to download the meta-analysis Prouse T, Mast AE, Ignjatovic V, Kovac M, Bereczky Z, Majumder R. Alternate functions of physiological anticoagulants. J Thromb Haemost. 2025:S1538-7836(25)00540-9. doi: 10.1016/j.jtha.2025.08.014. PMID: 40907701. Abstract The anticoagulant proteins antithrombin, protein C, protein S, and tissue factor pathway inhibitor are physiological regulators of the blood coagulation […]
read more

PT and PTT Illustrated Mechanisms

For an illustrated overview of the hemostasis mechanisms associated with the PT and PTT, obtain this article from your medical library: Harris NS, Marin MJ, Butenas S. Beyond prothrombin time and activated partial thromboplastin time: coagulation in vivo-an illustrated review. Lab Med. 2025;56:438–47. doi: 10.1093/labmed/lmae125. PMID: 40319459. Abstract The steps that initiate coagulation in vivo […]
read more

November 2025 QQ: Stuart-Prower Factor

Our November 2025 Quick Question tests our historical knowledge. Not long ago, we learned about various names for the coagulation factors; e. g., proaccelerin, proconvertin, and plasma thromboplastin antecedent. Some factor names were proper nouns, for example, Hageman factor, Fletcher factor, and Fitzgerald factor. This month’s question asks you to identify the Stuart-Prower factor by […]
read more

Cell-based Coagulation Overview

Check your medical library to read Harris NS, Marin MJ, Butenas S. Beyond prothrombin time and activated partial thromboplastin time: coagulation in vivo-an illustrated review. Lab Med. 2025;56:438–47. doi: 10.1093/labmed/lmae125. PMID: 40319459. Here’s the abstract: The steps that initiate coagulation in vivo are different from the components of prothrombin time (PT) and activated partial thromboplastin time […]
read more

Lab Assessment of FVIII Inhibitors

Click here for an open-access article describing the need for factor inhibitor assessment: Favaloro EJ, Curnow J, Pasalic L. Laboratory assessment of factor VIII inhibitors: when is it required? A perspective informed by local practice. J Clin Med. 2024;14:13. doi: 10.3390/jcm14010013. PMID: 39797095; PMCID: PMC11720995. See also our factor inhibitor discussions under the Bleeding Disorders heading.
read more